Author
Listed:
- Edyth Parker
(Redeemer’s University
The Scripps Research Institute)
- Ifeanyi F. Omah
(University of Edinburgh
Nnamdi Azikiwe University)
- Delia Doreen Djuicy
(Centre Pasteur du Cameroun)
- Andrew Magee
(University of California Los Angeles)
- Christopher H. Tomkins-Tinch
(The Broad Institute of MIT and Harvard)
- James Richard Otieno
(Theiagen Genomics)
- Patrick Varilly
(The Broad Institute of MIT and Harvard)
- Akeemat Opeyemi Ayinla
(Redeemer’s University)
- Ayotunde E. Sijuwola
(Redeemer’s University)
- Muhammad I. Ahmed
(Redeemer’s University)
- Oludayo O. Ope-Ewe
(Redeemer’s University)
- Olusola Akinola Ogunsanya
(Redeemer’s University)
- Alhaji Olono
(Redeemer’s University)
- Femi Mudasiru Saibu
(Redeemer’s University)
- Philomena Eromon
(Redeemer’s University)
- Moïse Henri Moumbeket Yifomnjou
(Centre Pasteur du Cameroun)
- Loique Landry Messanga Essengue
(Centre Pasteur du Cameroun)
- Martial Gides Wansi Yonga
(Centre Pasteur du Cameroun)
- Gael Dieudonné Essima
(Centre Pasteur du Cameroun)
- Ibrahim Pascal Touoyem
(Centre Pasteur du Cameroun)
- Landry Jules Mouliem Mounchili
(Centre Pasteur du Cameroun)
- Sara Irene Eyangoh
(Centre Pasteur du Cameroun)
- Alain Georges Mballa Etoundi
(Centre Pasteur du Cameroun)
- Linda Esso
(Ministry of Public Health)
- Inès Mandah Emah Nguidjol
(Ministry of Public Health)
- Steve Franck Metomb
(Ministry of Public Health)
- Cornelius Chebo
(Ministry of Public Health)
- Samuel Mbah Agwe
(Ministry of Public Health)
- Hans Makembe Mossi
(Ministry of Public Health)
- Chanceline Ndongo Bilounga
(Ministry of Public Health)
- Olusola Akanbi
(Nigeria Centre for Disease Control and Prevention)
- Abiodun Egwuenu
(Nigeria Centre for Disease Control and Prevention)
- Odianosen Ehiakhamen
(Nigeria Centre for Disease Control and Prevention)
- Chimaobi Chukwu
(Nigeria Centre for Disease Control and Prevention)
- Kabiru Suleiman
(Nigeria Centre for Disease Control and Prevention)
- Afolabi Akinpelu
(Nigeria Centre for Disease Control and Prevention)
- Adama Ahmad
(Nigeria Centre for Disease Control and Prevention)
- Khadijah Isa Imam
(Nigeria Centre for Disease Control and Prevention)
- Richard Ojedele
(Nigeria Centre for Disease Control and Prevention)
- Victor Oripenaye
(Nigeria Centre for Disease Control and Prevention)
- Kenneth Ikeata
(Nigeria Centre for Disease Control and Prevention)
- Sophiyah Adelakun
(Nigeria Centre for Disease Control and Prevention)
- Babatunde Olajumoke
(Nigeria Centre for Disease Control and Prevention)
- Áine O’Toole
(University of Edinburgh)
- Mark Zeller
(The Scripps Research Institute)
- Karthik Gangavarapu
(The Scripps Research Institute)
- Daniel J. Park
(The Broad Institute of MIT and Harvard)
- Gerald Mboowa
(Africa Centres for Disease Control and Prevention)
- Sofonias Kifle Tessema
(Africa Centres for Disease Control and Prevention)
- Yenew Kebede Tebeje
(Africa Centres for Disease Control and Prevention)
- Onikepe Folarin
(Redeemer’s University
Redeemer’s University)
- Anise Happi
(Redeemer’s University)
- Philippe Lemey
(KU Leuven)
- Marc A. Suchard
(University of California Los Angeles
University of California Los Angeles
University of California Los Angeles)
- Kristian G. Andersen
(The Scripps Research Institute
Scripps Research Translational Institute)
- Pardis Sabeti
(The Broad Institute of MIT and Harvard
Harvard T H Chan School of Public Health)
- Andrew Rambaut
(University of Edinburgh)
- Chikwe Ihekweazu
(Nigeria Centre for Disease Control and Prevention)
- Idris Jide
(Nigeria Centre for Disease Control and Prevention)
- Ifedayo Adetifa
(Nigeria Centre for Disease Control and Prevention)
- Richard Njouom
(Centre Pasteur du Cameroun)
- Christian T. Happi
(Redeemer’s University
Redeemer’s University
Harvard T H Chan School of Public Health)
Abstract
Five years before the 2022 multi-country mpox outbreak, Nigeria and Cameroon reported their first cases in more than three decades1,2. Whereas the outbreak in Nigeria is recognized as an ongoing human epidemic, the drivers of the resurgence in Cameroon remain unclear3,4. The rate of zoonoses remains uncertain in both countries, and gaps in genomic data obscure the timing and zoonotic and geographic origin of monkeypox virus (MPXV) emergence in humans. Here, to address these uncertainties, we sequenced 118 MPXV genomes isolated from cases in Nigeria and Cameroon between 2018 and 2023. We show that in contrast to cases in Nigeria, cases in Cameroon are the result of repeated zoonoses, with two distinct zoonotic lineages circulating across the Nigeria–Cameroon border. Our findings suggest that shared animal populations in the cross-border forest ecosystems drive the emergence and spread of the virus. Accordingly, we identify the closest zoonotic outgroup to the Nigerian human epidemic lineage (hMPXV-1) in a southern Nigerian border state. We estimate that the shared ancestor of the zoonotic outgroup and hMPXV-1 circulated in animals in southern Nigeria in late 2013. We find that hMPXV-1 emerged in humans in August 2014 in the southern Rivers State and circulated undetected for three years. Rivers State was the main source of viral spread during the human epidemic. Our study sheds light on the recent establishment of MPXV in the human population and highlights the risk of persistent zoonotic emergence of MPXV in the complex border regions of Cameroon and Nigeria.
Suggested Citation
Edyth Parker & Ifeanyi F. Omah & Delia Doreen Djuicy & Andrew Magee & Christopher H. Tomkins-Tinch & James Richard Otieno & Patrick Varilly & Akeemat Opeyemi Ayinla & Ayotunde E. Sijuwola & Muhammad I, 2025.
"Genomics reveals zoonotic and sustained human mpox spread in West Africa,"
Nature, Nature, vol. 643(8074), pages 1343-1351, July.
Handle:
RePEc:nat:nature:v:643:y:2025:i:8074:d:10.1038_s41586-025-09128-2
DOI: 10.1038/s41586-025-09128-2
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:643:y:2025:i:8074:d:10.1038_s41586-025-09128-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.